Recently, we published a blog that addressed the question of how many people with diabetes would a small-scale system could serve. Through our calculation, we estimated that a small-scale production system could serve an expected total of 13,000 people with diabetes; the estimates range from 4,000 to 45,000. In this post, we would like to […]
Greetings! Here is a quick overview of the most common information people tend to look for when first learning about the Open Insulin project. Goals We’re making a complete open source system for making insulin at a small scale. This includes organisms to make at least one long acting and one rapid acting insulin, and […]
The Open Insulin Project is working to create an open-source model for distributed and decentralized insulin manufacturing. For over four years, team members have volunteered to make this idea a reality, bringing attention to the outrageous and unaffordable price of insulin. Our work has garnered widespread attention, and we have been featured in the Time […]
We face a key problem in responding to the coronavirus epidemic: a lack of resources needed to carry out testing. One of the main problems with existing manufacturing systems is that the infrastructure is inflexible. Medicines, supplies, and scientific equipment needed to respond to an outbreak like that of the coronavirus cannot be made in […]
Input is welcome! Let’s crowdsource this! Open Insulin has proposed small-scale, localized production of insulin as a way to address large-scale, centralized manufacturing that contributes to oligopolic control over insulin production and access. We get asked how many people this type of small-scale system could serve. This post is an attempt to answer that question. […]